It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lipopolysaccharide (LPS) O-antigen (O-Ag) is known to limit antibody binding to surface antigens, although the relationship between antibody, O-Ag and other outer-membrane antigens is poorly understood. Here we report, immunization with the trimeric porin OmpD from Salmonella Typhimurium (STmOmpD) protects against infection. Atomistic molecular dynamics simulations indicate this is because OmpD trimers generate footprints within the O-Ag layer sufficiently sized for a single IgG Fab to access. While STmOmpD differs from its orthologue in S. Enteritidis (SEn) by a single amino-acid residue, immunization with STmOmpD confers minimal protection to SEn. This is due to the OmpD-O-Ag interplay restricting IgG binding, with the pairing of OmpD with its native O-Ag being essential for optimal protection after immunization. Thus, both the chemical and physical structure of O-Ag are key for the presentation of specific epitopes within proteinaceous surface-antigens. This enhances combinatorial antigenic diversity in Gram-negative bacteria, while reducing associated fitness costs.
The O-antigen of LPS is known to limit the binding of antibody to bacterial surface antigens. Here the AUs show that the chemical and physical structure of the O-antigen are central factors in limiting the exposure of surface antigens to antibodies during Salmonella infection, thus defining their protective qualities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Birmingham, Institute of Microbiology and Infection, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
2 University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Birmingham, Institute of Microbiology and Infection, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); Specialties Hospital, National Medical Centre “Siglo XXI” Mexican Institute for Social Security, Medical Research Unit on Immunochemistry, Mexico City, Mexico (GRID:grid.419157.f) (ISNI:0000 0001 1091 9430)
3 University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
4 Georgia Institute of Technology, School of Materials Science and Engineering, Atlanta GA, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
5 University of Cape Town, Institute of Infectious Disease and Molecular Medicine, Western Cape, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151)
6 University of Birmingham, Institute of Microbiology and Infection, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
7 University of Nottingham, School of Veterinary Medicine and Science, Sutton Bonington, UK (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868)
8 University of Oxford, Jenner Institute, Nuffield Department of Medicine, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
9 University of Newcastle, Institute for Cell and Molecular Biosciences, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
10 Georgia Institute of Technology, School of Physics, Atlanta, USA (GRID:grid.213917.f) (ISNI:0000 0001 2097 4943)
11 Specialties Hospital, National Medical Centre “Siglo XXI” Mexican Institute for Social Security, Medical Research Unit on Immunochemistry, Mexico City, Mexico (GRID:grid.419157.f) (ISNI:0000 0001 1091 9430)
12 University of Essex, Wivenhoe Park, School of Life Sciences, Colchester, UK (GRID:grid.8356.8) (ISNI:0000 0001 0942 6946)